Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45]

Affiliations

¹ Department of Obstetrics and Gynecology, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: StephanieA.scott@nshealth.ca.
² Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
³ Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada.
⁴ Division of Gynecologic-Oncology, Centre Hospitalier de Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, Quebec, Canada.
⁵ Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada.
⁶ Department of Obstetrics and Gynecology, Dalhousie University, Halifax, Nova Scotia, Canada.
⁷ Department of Pathology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
⁸ Department of Pathology and Molecular Medicine, Health Research Methods, Evaluation, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
⁹ Department of Pathology and Molecular Medicine, McMaster University and The Juravinski Hospital and Cancer Centre, Hamilton, Ontario, Canada.
¹⁰ Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.

Published Erratum

Stephanie A Scott et al. Gynecol Oncol. 2022 Nov.

. 2022 Nov;167(2):399.

doi: 10.1016/j.ygyno.2022.10.009.

¹ Department of Obstetrics and Gynecology, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: StephanieA.scott@nshealth.ca.
² Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
³ Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada.
⁴ Division of Gynecologic-Oncology, Centre Hospitalier de Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, Quebec, Canada.
⁵ Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada.
⁶ Department of Obstetrics and Gynecology, Dalhousie University, Halifax, Nova Scotia, Canada.
⁷ Department of Pathology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
⁸ Department of Pathology and Molecular Medicine, Health Research Methods, Evaluation, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
⁹ Department of Pathology and Molecular Medicine, McMaster University and The Juravinski Hospital and Cancer Centre, Hamilton, Ontario, Canada.
¹⁰ Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.

No abstract available

Erratum for

Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes.
Scott SA, Llaurado Fernandez M, Kim H, Elit L, Nourmoussavi M, Glaze S, Roberts L, Offman SL, Rahimi K, Lytwyn A, Sur M, Gilks CB, Matheson K, Köbel M, Dawson A, Tinker AV, Kwon JS, Hoskins P, Santos JL, Cheung A, Provencher D, Carey MS; Canadian LGSC Community of Practice (GOC-CoP). Scott SA, et al. Gynecol Oncol. 2020 Apr;157(1):36-45. doi: 10.1016/j.ygyno.2020.01.021. Epub 2020 Jan 27. Gynecol Oncol. 2020. PMID: 32001076